Expert consensus on off-label drug use in the three Northeastern provinces of China（solid tumors and hematology）
- VernacularTitle:东北三省超说明书用药专家共识（实体瘤、血液病篇）
- Author:
Yao JIN
1
;
Zhiqiang TONG
1
;
Mei DONG
1
;
Shuang CAI
2
Author Information
1. Dept. of Pharmacy，Harbin Medical University Cancer Hospital，Harbin 150086，China
2. Dept. of Pharmacy，the First Affiliated Hospital of China Medical University，Shenyang 110001，China
- Publication Type:Journal Article
- Keywords:
off-label drug use;
solid tumors;
hematology;
three Northeastern provinces of China;
rational drug use;
expert
- From:
China Pharmacy
2023;34(23):2817-2824
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide theoretical basis for the rational use of drugs in medical institutions， assist in improving the quality of pharmaceutical services， and thus meet clinical drug demands. METHODS Adopting consensus meetings， Liaoning Pharmaceutical Association，Jilin Pharmaceutical Association and Heilongjiang Pharmaceutical Association collaborated with clinical and pharmaceutical experts in the region to compile the expert consensus on off-label drug use in the three Northeastern provinces of China after many votes and discussions by collecting and collating the information related to off-label drug use in medical institutions from the three northeastern provinces of China，and referring to and citing off-label drug use stated in some expert consensus and medication catalog. RESULTS Finally， a total of 198 pieces of off-label drug use information for 70 drugs were included in the two sections of solid tumors and hematological diseases in Consensus of Experts on Drug Use beyond the Instructions in the Three Provinces of Northeast China. CONCLUSIONS Consensus of Experts on Off-label Drug Use in the Three Northeastern Provinces of Northeast China （solid tumors and hematology）offers a theoretical foundation for rational drug use in the treatment of solid tumors and hematological diseases within medical institutions，and has a positive significance in improving the effectiveness and safety of drug treatment.
